Abstract:Background: Previous studies demonstrated that adventitia fibroblasts exhibit important role in the hyperplasia of newly born endomembrane after blood vessel injury. However, the mechanism regarding phenotypic transition of adventitia fibroblasts in vitro remains unclear. Objective: To observe effect of peroxisome proliferators-activated receptor γ agonist (PPAR γ) on phenotypic transition of adventitia fibroblasts induced by transforming growth factor β 1 (TGF-β 1) in vitro, as well as the expression of collagen protein I. Design, Time and Setting: A randomized grouping control experiment was performed at the Tissue Engineering Laboratory of Ninth Affiliated Hospital of Shanghai Jiao Tong Medical College between July 2007 and October 2008. Materials: The aorta thoracica's adventitial fibroblasts were cultured from Sprague Dawley rats, with 2-month-old, weighing 120 g. The TGF-β 1 was supplied by American GenWay Biotech Company. The rosiglitazone power was purchased from Beijing Comens Chemical Co., Ltd. Methods: The experiment was divided into 3 groups: In the TGF-β 1 group, fibroblasts was induced with TGF-β 1 with different concentrations(3, 5, 10, 15 μ g/L) for 48 hours; in the rosiglitazone group, fibroblasts was induced with rosiglitazone (5, 10, 30, 50 μ mol/L) for 45 minutes followed by co-culture with 10 μ g/L TGF-β 1 for 48 hours. There was no intervention measure in the control group. Main Outcome Measures: The phenotypic transition of fibroblasts was measured by α-smooth muscle actin, the expression of smooth muscle α 2-actin, as well as collagen type I was determined by protein immunoblotting. Results: Compared with the control group, 5 μ g/L TGF-β 1 could significantly stimulate the changes of phenotypic transition of fibroblasts as well as the expression of smooth muscle α 2-actin and Collagen type I, which reach a peak level when treated with 10 μ g/L TGF-β, (P < 0.05). The expression of smooth muscle α 2-actin and collagen type I would not increase with the increasing of TGF-β 1 to 15 μ g/L, compared with 10 μ g/L TGF-β 1 group (P> 0.05). Compared with control group, 30 μ mol/L rosiglitazone could significantly inhibit changes of phenotypic transition of fibroblasts as well as the expression of smooth muscle α 2-actin and collagen type I (P<0.05). Conclusion: PPAR-γ agonist rosiglitazone can inhibit the phenotypic transition of adventitia fibroblasts induced by TGF-β 1, as well as the expression of smooth muscle α 2-actin and collagen type I.

Effects of Peroxisome Proliferators-Activatied Receptor Gamma on the Biological Characteristics of Hepatic Stellate Cells

Effect of Ligand of Peroxisome Proliferator-Activated Receptor Gamma on the Biological Characters of Hepatic Stellate Cells

A specific ligand of peroxisome proliferator-activated receptor gamma suppressing activation of hepatic stellate cells

Mechanism of Rosiglitazone Suppressing the Activation of Hepatic Stellate Cells

Rosiglitazone ameliorates the dysfunction of endothelial progenitor cells induced by advanced glycation end products

Rosiglitazone depresses activation of rat hepatic stellate cells in vitro

Rosiglitazone Via Upregulation of Akt/Enos Pathways Attenuates Dysfunction of Endothelial Progenitor Cells, Induced by Advanced Glycation End Products

Effects of Rosiglitazone on Serum Levels of Lipids and Inflammatory Factors in Atherosclerotic Rats

[The Effect of Ligand of Peroxisome Proliferators-Activated Receptor Gamma 15D-Pgj2 on the Proliferation and Activation of Hepatic Stellate Cells].

Peroxisome proliferator activated receptor gamma ligand suppresses hepatic fibrosis in rats

Regulation of Peroxisome Proliferator-Activated Receptor-Gamma Activity Affects the Hepatic Stellate Cell Activation and the Progression of NASH Via TGF-β1/Smad Signaling Pathway

Effect of Peroxisome Proliferator-Activated Receptor Γ Agonist on Prostate Epithelial Cells

Effects of rosiglitazone on expressions of peroxisome proliferator-activated receptor gamma and TGF-β1 in rats with adriamycin nephrosis

Peroxisome Proliferator-Activated Receptors Gamma Reverses Hepatic Nutritional Fibrosis in Mice and Suppresses Activation of Hepatic Stellate Cells in Vitro.

Effects of Pioglitazone on the Morphology and the Expression of Connective Tissue Growth Factor of Transforming Growth Factor Beta-Induced Rat Hepatic Stellate Cells in Vitro

Effects of PPAR-γ activation on angiotensin Ⅱ-induced extra cellular matrix production and CTGF expression in VSMCs

PPAR Gamma Inhibits Growth of Rat Hepatic Stellate Cells and TGF Beta-Induced Connective Tissue Growth Factor Expression

Effect of peroxisome proliferators-activated receptor gamma agonist on phenotypic transition of adventitia fibroblasts induced by transforming growth factor beta 1 in vitro

18Α‐glycyrrhetinic Acid Extracted from Glycyrrhiza Radix Inhibits Proliferation and Promotes Apoptosis of the Hepatic Stellate Cell Line

Effects of peroxisome proliferator-activated receptor gamma on airway mucus production in a murine model of asthma

Effect of rosiglitazone on aquaporin-1 expression in human peritoneal mesothelial cells and human umbilical vein endothelial cells